US Patent Issued to AUTOBAHN THERAPEUTICS on May 26 for "Fatty acid amide hydrolase (FAAH) cleavable prodrugs of thyromimetics and combination with peripherally restricted FAAH inhibitors" (California Inventors)

ALEXANDRIA, Va., May 26 -- United States Patent no. 12,637,413, issued on May 26, was assigned to AUTOBAHN THERAPEUTICS INC. (San Diego).

"Fatty acid amide hydrolase (FAAH) cleavable prodrugs of thyromimetics and combination with peripherally restricted FAAH inhibitors" was invented by Brian Andrew Stearns (San Diego), Jill Melissa Baccei (San Diego) and Jason Randall Harris (San Diego).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are fatty acid amide (FAAH) cleavable prodrugs of thyromimetics and pharmaceutical compositions comprising these compounds with at least one pharmaceutically acceptable excipient further comprising a peripherally restricted FAAH inhibitor."

The patent was filed on...